COVID-19 pneumonia In the 23 October 2020 issue of Science, Zhang et al. report on early results of the COVID...
In the October 2020 issue of Cell, a University of Pittsburgh group led by Dr. Dimiter S. Dimitrov reports on...
Silver magic bullet – COVID-19 Reuters, BBC and other major media reported that the World Health Organization (WHO) warned on...
Antiviral Remdesivir – Efficacy in an Animal Model As reported by Brandi Williamson et al. in bioRxiv, remdesivir is the...
Raloxifene – M2-Macrophage Shift – High IL-10 A new study published in the journal Inflammation indicates that in myeloid cells...
Catecholamines Inhibit IL-27 Production A recent J. Immunology study provides perhaps the first evidence that catecholamines such as norepinephrine and...
Bamlanivimab – Treatment of Mild to Moderate COVID-19 On November 9, 2020, the U.S. Food and Drug Administration (FDA) issued...
NIH – randomized controlled trial As reported on Thursday, August 6, 2020, the National Institutes of Health (NIH), Bethesda, MD...
Remdesivir: The European Commission Approves this Drug for the Treatment of Severe Cases of COVID-19
Remdesivir – European Commission Following the recommendation of the European Medicines Agency (EMA), the European Commission has authorized on Friday,...
Immunomodulatory and anti-inflammatory neuropeptides – gut Researches from Spain and Portugal showed, for the first time, the production of neuropeptides...
Norepinephrine down-regulates pro-inflammatory pathogenic Th17 cells A recent study in Medical Science Monitor indicates that norepinephrine (noradrenaline), the major sympathetic...
Vagus Nerve Stimulation – Joint Inflammation A recent study published in the Brain, Behavior, and Immunity journal indicates, for the first...